Phathom Pharmaceuticals I... (PHAT)
6.76
-0.03 (-0.44%)
At close: Jan 15, 2025, 11:41 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -201.59M | -197.72M | -143.88M | -129.07M | -255.13M | -1.29M |
| Depreciation & Amortization | 575.00K | 620.00K | 521.00K | 323.00K | 8.00K | n/a |
| Stock-Based Compensation | 45.02M | 24.13M | 16.81M | 5.84M | 406.00K | n/a |
| Other Working Capital | -8.97M | -3.24M | -17.68M | 27.71M | -11.79M | -10.00K |
| Other Non-Cash Items | 32.06M | 21.00M | 5.41M | 1.59M | 131.46M | 50.00K |
| Deferred Income Tax | n/a | n/a | n/a | -95.00K | 96.27M | n/a |
| Change in Working Capital | -13.64M | 5.44M | -27.48M | 51.72M | -9.52M | 215.00K |
| Operating Cash Flow | -137.58M | -146.53M | -148.62M | -69.69M | -36.51M | -1.02M |
| Capital Expenditures | -1.63M | -1.04M | -328.00K | -1.04M | -25.25M | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -1.18M | -330.00K | -1.19M | -25.12M | n/a |
| Investing Cash Flow | -1.63M | -1.04M | -328.00K | -1.04M | -25.25M | n/a |
| Debt Repayment | 39.32M | n/a | 42.76M | 25.00M | 24.85M | 1.90M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 172.80M | 95.45M | 1.94M | 629.00K | 279.80M | 2.00K |
| Financial Cash Flow | 367.58M | 120.04M | 44.71M | 114.46M | 304.65M | 1.90M |
| Net Cash Flow | 228.37M | -27.53M | -104.24M | 43.73M | 242.89M | 879.00K |
| Free Cash Flow | -139.21M | -147.57M | -148.94M | -70.73M | -61.76M | -1.02M |